Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)
NCT06432569
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
DIETARY_SUPPLEMENT:
ButirBioma + PeaBioma
DIETARY_SUPPLEMENT:
Placebo
Sponsor
University of Padova